News Quantified

CRSP – crispr therapeutics ag - common shares (US:NASDAQ)

CRISPR Therapeutics AG (CRSP) Rises Higher Than Market: Key Facts [Yahoo! Finance]

4/22

06:04 am

crsp

Low

CRISPR Therapeutics (CRSP) had its "sell (d-)" rating reaffirmed by Weiss Ratings.

CRISPR Therapeutics Has Major Catalysts Ahead. Is This Biotech Stock a Screaming Buy? [Yahoo! Finance]

CRISPR Therapeutics Has Major Catalysts Ahead. Is This Biotech Stock a Screaming Buy? [Globe and Mail, The (Toronto, Canada)]

Assessing CRISPR Therapeutics (CRSP) Valuation After Recent Share Price Performance [Yahoo! Finance]

Live Event: Join our next subscriber-only event: "The Data Driven Investor"

Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}